Salidroside alleviates cholestasis-induced liver fibrosis by inhibiting hepatic stellate cells via activation of the PI3K/AKT/GSK-3β signaling pathway and regulating intestinal flora distribution
Article in Frontiers in Pharmacology (May 2024)
The most recent citing publications are shown below. View all 45 publications that cite this research output on Dimensions.
Article in Frontiers in Pharmacology (May 2024)
Article in Naunyn-Schmiedeberg's Archives of Pharmacology (March 2024)
Article in European Journal of Pharmacology (March 2024)